David Miceli joined the Firm’s pharmaceutical litigation department Of Counsel in 2006. Based in Georgia, David has practiced law for twenty years and specializes in complex pharmaceutical and medical device ...
Recent research has linked low testosterone
treatments such as Androgel, Androderm, Axiron, Delatestryl, Fortesta, Testopel and more to an increased risk of heart attack, stroke or death when taken by men with heart problems.
At Simmons Hanly Conroy, we’re dedicated to our clients and communities. We have donated nearly $20 million to cancer research and we support a variety of organizations including the American Lung Association, American Red Cross, Salvation Army, and more.
Simmons Hanly Conroy is a national law firm with offices in Chicago, St. Louis, San Francisco, Los Angeles and Alton, Illinois. We have the resources necessary to prosecute pharmaceutical drug and device ligation. We are also dedicated to giving our clients the personal attention and the respect they deserve, no matter where they live.
September 29, 2014 - Simmons Hanly Conroy Elevates Eight Attorneys to Shareholder
Articles & analysis from the Firm attorneys and staff.
December 18, 2014 - FDA Advisers Shown to Have Questionable Financial Ties
December 17, 2014 - The History of Risperdal FDA Warnings
December 16, 2014 - Blood Thinners Like Xarelto and Pradaxa Classified as “Dangerous”: Here’s Why